ARTICLES BY CARLA REED

• The Need For Digital Networks To Support Cell And Gene Therapies

  12/30/2019

  Cell and gene therapies have a level of complexity from a supply chain perspective that needs new approaches, including a high level of information sharing and integration. This topic was covered from different perspectives at two recent conferences.

• 8 Critical Elements Of A Supply Chain Strategy — From Discovery To Commercialization

  6/25/2018

  The journey from discovery to commercialization can be long and filled with obstacles and challenges. However, by taking a structured approach to the development of a clearly defined supply chain and distribution strategy, the path toward the ultimate goal can be a clear one.

• Selecting Secondary Packaging For Bio/Pharma Products

  4/6/2018

  Secondary packaging, at times an overlooked element of product life cycle management, should provide protection for the material or product across all the process steps, from final packaging at production through consumption, return, and disposal. 

• Environmental Risks & The Life Science Supply Chain: Lessons Learned From Hurricane Maria

  1/15/2018

  Looking back at the hurricane season from the perspective of supply chain risk — and specifically risks that have impacted the life sciences supply chain — there are many lessons to be learned.

• A Life Cycle Management Approach To Developing A Supply Chain Strategy

  9/6/2017

  Adopting a life cycle management approach will assist in identifying risk factors and constraints and provide structure and control, with a clearly defined methodology to identify and mitigate risk.

• 5 Proven Steps To Successfully Select & Onboard Outsourced Logistics Partners

  1/23/2017

  In preceding articles in this series, we reviewed some of the challenges and remediation approaches for the storage and distribution of life science products, highlighting some of the specific risks related to storage, transportation, and material control across an extended chain of custody. This brings us to the final article, in which we will discuss best practices for selecting the partners that will be an extension of your staff for monitoring and control across an ever-changing global landscape.

• A Risk-Based Approach To Environmental Monitoring & Control For Pharmaceutical Distribution

  10/20/2016

  Over the past few decades, many companies have spent time and capital investment in assessing and mitigating risk factors across the extended supply chain. However, even for those companies that have designed and implemented state-of-the-art operational supply and logistics networks, there is always risk that products may be impacted by variations in temperature, humidity, or other deviations from ideal conditions at any stage across the chain of custody.

• A cGDP Primer: New Distribution Models For Life Science Supply Chains

  9/2/2016

  The life sciences industry has undergone many changes over the last decade, with consolidation, mergers, and acquisitions across both small and large pharmaceutical and biotech companies. One result of these changes is complex supply chain models, with a combination of in-house and outsourced research, product development, and commercial operations. The level of complexity has presented challenges for stakeholders and their supply chain partners: suppliers of materials, components, and packaging, as well as contract research (CRO), contract manufacturing (CMO), and logistics service providers.